158 related articles for article (PubMed ID: 32769852)
1. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan.
Kowada A
Pancreas; 2020 Sep; 49(8):1052-1056. PubMed ID: 32769852
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis.
Corral JE; Das A; Bruno MJ; Wallace MB
Pancreas; 2019 Apr; 48(4):526-536. PubMed ID: 30946242
[TBL] [Abstract][Full Text] [Related]
3. Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma.
Kumar S; Saumoy M; Oh A; Schneider Y; Brand RE; Chak A; Ginsberg GG; Kochman ML; Canto MI; Goggins MG; Hur C; Kastrinos F; Katona BW; Rustgi AK
Pancreas; 2021 Jul; 50(6):807-814. PubMed ID: 34149034
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
5. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of MicroRNA for Pancreatic Cancer Screening in Patients With Diabetes.
Kowada A
Pancreas; 2022 Sep; 51(8):1019-1028. PubMed ID: 36607949
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of magnetic resonance imaging versus ultrasound for the detection of symptomatic full-thickness supraspinatus tendon tears.
Gyftopoulos S; Guja KE; Subhas N; Virk MS; Gold HT
J Shoulder Elbow Surg; 2017 Dec; 26(12):2067-2077. PubMed ID: 28893546
[TBL] [Abstract][Full Text] [Related]
8. Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion: Cost-Effectiveness Analysis.
Beyer SE; Hunink MG; Schöberl F; von Baumgarten L; Petersen SE; Dichgans M; Janssen H; Ertl-Wagner B; Reiser MF; Sommer WH
Stroke; 2015 Jul; 46(7):1840-9. PubMed ID: 26022634
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds.
Rulyak SJ; Kimmey MB; Veenstra DL; Brentnall TA
Gastrointest Endosc; 2003 Jan; 57(1):23-9. PubMed ID: 12518126
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.
Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM
World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial.
Gangi A; Malafa M; Klapman J
Pancreas; 2018; 47(5):586-591. PubMed ID: 29683970
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of Imaging Protocols for Suspected Appendicitis.
Jennings R; Guo H; Goldin A; Wright DR
Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31964758
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm.
Ehlers L; Overvad K; Sørensen J; Christensen S; Bech M; Kjølby M
BMJ; 2009 Jun; 338():b2243. PubMed ID: 19553267
[TBL] [Abstract][Full Text] [Related]
17. Challenges in diagnosis of pancreatic cancer.
Zhang L; Sanagapalli S; Stoita A
World J Gastroenterol; 2018 May; 24(19):2047-2060. PubMed ID: 29785074
[TBL] [Abstract][Full Text] [Related]
18. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program.
Joergensen MT; Gerdes AM; Sorensen J; Schaffalitzky de Muckadell O; Mortensen MB
Pancreatology; 2016; 16(4):584-92. PubMed ID: 27090585
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of contrast-enhanced ultrasound for the detection of endovascular aneurysm repair-related endoleaks requiring treatment.
Froelich MF; Kunz WG; Kim SH; Sommer WH; Clevert DA; Rübenthaler J
J Vasc Surg; 2021 Jan; 73(1):232-239.e2. PubMed ID: 32442612
[TBL] [Abstract][Full Text] [Related]
20. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
